← Back to Search

Community Mobilization for High Blood Pressure

N/A
Waitlist Available
Led By Olugbenga Ogedegbe, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 24
Awards & highlights

Summary

This trial will use the EPIS model in a type-2 hybrid design to explore barriers and facilitators of Clean Fuel-Clean-Stove (CF-CS) use, develop a culturally-tailored CM strategy for CF-CS use, and compare the effect of CM vs. a self-directed condition (i.e. receipt of information on CF-CS use without CM) on adoption of CF-CS use and systolic BP reduction in a cluster RCT of 640 households across 32 peri-urban communities in Nigeria.

Who is the study for?
This trial is for families in peri-urban Nigerian communities who primarily use kerosene, charcoal, or firewood for cooking. The primary cook must be a female without a paid housemaid, and the household should have 2 to 7 members. The key decision-maker at home must agree to participate and not plan to move within the next year.
What is being tested?
The study tests if community mobilization (CM) can increase clean cookstove usage and reduce hypertension compared to just giving information without CM support. It's conducted in three phases: exploring barriers, implementing CM in a randomized trial of 640 households across 32 communities, then checking long-term sustainability.
What are the potential side effects?
Since this intervention involves social strategies rather than medical treatments, there are no direct side effects like you'd expect with drugs. However, changes in cooking practices could indirectly affect lifestyle or health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of Participants who have Adopted CF-CS at Baseline
Percent of Participants who have Adopted CF-CS at Month 12
Secondary study objectives
Change in Mean Systolic Blood Pressure from Baseline to Month 12
Percent of Participants who Have Adopted CF-CS at Month 24

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CM Intervention GroupExperimental Treatment1 Intervention
Cluster. RCT of 16 urban and rural communities. Community mobilizers and health education officers will facilitate use of CF-CS (bioethanol and LPG fuels/stoves) and educate households on HAP exposure throughout the intervention period
Group II: Self-Directed GroupActive Control1 Intervention
Receive information on CFCS use and education on HAP in 16 urban and rural communities; will not receive the CM intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Community Mobilization
2011
N/A
~71890

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,832,927 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,397 Previous Clinical Trials
860,562 Total Patients Enrolled
Olugbenga Ogedegbe, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
830 Total Patients Enrolled

Media Library

Community Mobilization Clinical Trial Eligibility Overview. Trial Name: NCT05048147 — N/A
High Blood Pressure Research Study Groups: Self-Directed Group, CM Intervention Group
High Blood Pressure Clinical Trial 2023: Community Mobilization Highlights & Side Effects. Trial Name: NCT05048147 — N/A
Community Mobilization 2023 Treatment Timeline for Medical Study. Trial Name: NCT05048147 — N/A
~291 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top